Skip to main
GL

GL Stock Forecast & Price Target

GL Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

Globe Life Inc. is poised for positive growth, with life premium growth targeted at 4.0%-4.5% and health premium estimated to rise significantly by 14%-16% in the coming year, reflecting strong demand for its insurance products. The company is actively ramping up marketing efforts, projecting a 10% increase in leads generated for its exclusive agencies, which should further drive sales across its segments. Financial performance indicators, such as a notable remeasurement gain of $150 million in the third quarter and favorable mortality experience, suggest robust operational health and support increased earnings per share estimates for 2025 and 2026.

Bears say

Globe Life Inc. has projected relatively modest operating earnings per share growth of only 3% at the midpoint for 2026, primarily influenced by significant assumption updates and a notable decrease in Life remeasurement gains from $192 million to an anticipated $50-$100 million. Additional risks include ongoing EEOC reviews related to employee allegations, increasing health utilization that may compress margins, and challenges in salesforce recruitment affecting topline growth. The underwriting margins are expected to be under pressure, particularly in the supplemental health insurance segment, where profitability is diminished by shifts toward lower-margin Medicare Supplement products.

GL has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Globe Life Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Globe Life Inc (GL) Forecast

Analysts have given GL a Buy based on their latest research and market trends.

According to 9 analysts, GL has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $170, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $170, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Globe Life Inc (GL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.